Literature DB >> 19821153

Plk1 phosphorylation of Topors is involved in its degradation.

Xiaoming Yang1, Hongchang Li, Anping Deng, Xiaoqi Liu.   

Abstract

Topors is a DNA topoisomerase I- and p53-binding protein, and mainly functions as a p53 regulator. Accumulating evidence also supports the notion that Topors plays the role as a negative regulator of cell growth, and possibly as a tumor suppressor. Here, we demonstrated that Topors is also involved in normal mitotic progression, since Topors depletion delays mitotic entry and affects mitotic progression. Furthermore, Topors is degradated in response to the activation of the spindle checkpoint. Significantly, Polo-like kinase 1 (Plk1)-associated phosphorylation of Topors at S718 is essential for nocodazole-induced degradation of Topors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19821153      PMCID: PMC4965875          DOI: 10.1007/s11033-009-9871-1

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  19 in total

1.  Identification of a novel gene encoding a p53-associated protein.

Authors:  R Zhou; H Wen; S Z Ao
Journal:  Gene       Date:  1999-07-22       Impact factor: 3.688

2.  Interaction between human topoisomerase I and a novel RING finger/arginine-serine protein.

Authors:  P Haluska; A Saleem; Z Rasheed; F Ahmed; E W Su; L F Liu; E H Rubin
Journal:  Nucleic Acids Res       Date:  1999-06-15       Impact factor: 16.971

Review 3.  Polo-like kinases: conservation and divergence in their functions and regulation.

Authors:  Vincent Archambault; David M Glover
Journal:  Nat Rev Mol Cell Biol       Date:  2009-04       Impact factor: 94.444

4.  topors, a p53 and topoisomerase I-binding RING finger protein, is a coactivator of p53 in growth suppression induced by DNA damage.

Authors:  Ling Lin; Toshinori Ozaki; Yuki Takada; Hajime Kageyama; Yoko Nakamura; Akira Hata; Jian-Hua Zhang; William F Simonds; Akira Nakagawara; Haruhiko Koseki
Journal:  Oncogene       Date:  2005-05-12       Impact factor: 9.867

Review 5.  Microtubule disruptors and their interaction with biotransformation enzymes.

Authors:  Martin Modrianský; Zdenĕk Dvorák
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2005-12       Impact factor: 1.245

6.  Topors acts as a SUMO-1 E3 ligase for p53 in vitro and in vivo.

Authors:  Stefan Weger; Eva Hammer; Regine Heilbronn
Journal:  FEBS Lett       Date:  2005-09-12       Impact factor: 4.124

Review 7.  Polo-like kinases and oncogenesis.

Authors:  Frank Eckerdt; Juping Yuan; Klaus Strebhardt
Journal:  Oncogene       Date:  2005-01-10       Impact factor: 9.867

8.  Topors functions as an E3 ubiquitin ligase with specific E2 enzymes and ubiquitinates p53.

Authors:  Rajeev Rajendra; Diptee Malegaonkar; Pooja Pungaliya; Henderson Marshall; Zeshaan Rasheed; James Brownell; Leroy F Liu; Stuart Lutzker; Ahamed Saleem; Eric H Rubin
Journal:  J Biol Chem       Date:  2004-07-09       Impact factor: 5.157

9.  The topoisomerase I- and p53-binding protein topors is differentially expressed in normal and malignant human tissues and may function as a tumor suppressor.

Authors:  Ahamed Saleem; Jayeeta Dutta; Diptee Malegaonkar; Farheena Rasheed; Zeshaan Rasheed; Rajeev Rajendra; Henderson Marshall; Minje Luo; Honghua Li; Eric H Rubin
Journal:  Oncogene       Date:  2004-07-08       Impact factor: 9.867

10.  The E3 ligase Topors induces the accumulation of polysumoylated forms of DNA topoisomerase I in vitro and in vivo.

Authors:  Eva Hammer; Regine Heilbronn; Stefan Weger
Journal:  FEBS Lett       Date:  2007-10-30       Impact factor: 4.124

View more
  4 in total

1.  Plk1-mediated phosphorylation of UAP56 regulates the stability of UAP56.

Authors:  Fuyin Xiong; Yanli Lin; Zhengbin Han; Gengshou Shi; Liyuan Tian; Xiaojie Wu; Qiangcheng Zeng; Yanrong Zhou; Jixian Deng; Hongxing Chen
Journal:  Mol Biol Rep       Date:  2011-06-03       Impact factor: 2.316

2.  Jade-1S phosphorylation induced by CK1α contributes to cell cycle progression.

Authors:  Lori Borgal; Markus M Rinschen; Claudia Dafinger; Valérie I Liebrecht; Hinrich Abken; Thomas Benzing; Bernhard Schermer
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

Review 3.  Plk1 Inhibitors in Cancer Therapy: From Laboratory to Clinics.

Authors:  Rosie Elizabeth Ann Gutteridge; Mary Ann Ndiaye; Xiaoqi Liu; Nihal Ahmad
Journal:  Mol Cancer Ther       Date:  2016-06-21       Impact factor: 6.261

Review 4.  Regulatory functional territory of PLK-1 and their substrates beyond mitosis.

Authors:  Shiv Kumar; Garima Sharma; Chiranjib Chakraborty; Ashish Ranjan Sharma; Jaebong Kim
Journal:  Oncotarget       Date:  2017-06-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.